The U.S. Food and Drug Administration says it has approved new labeling for another opioid designed to limit painkiller abuse. The FDA said Friday that Pfizer Inc.'s Embeda can have labeling indicating that it has properties expected to reduce abuse of the drug when it is crushed and taken orally or snorted.
President Barack Obama on Friday turned to a trusted adviser to lead the nation's Ebola response as efforts to clamp down on any possible route of infection from three Texas cases expanded, reaching a cruise ship at sea and multiple airline flights.
Chimerix has received FDA clearance to proceed with a trial examining the safety and effectiveness of its brincidofovir tablets in patients who have the virus.
The lawsuit was filed as a result of Actavis submitting an Abbreviated New Drug Application to the FDA in which Actavis is seeking approval to market and sell a generic version of Brisdelle® capsules prior to the expiration of the patents.
Aduro Expands Collaboration with Johnson & Johnson Innovation and Janssen for Lung Cancer ImmunotherapiesOctober 17, 2014 8:40 am | News | Comments
Under the agreement, facilitated by the Johnson & Johnson Innovation center in California, Aduro will receive a $30M up-front payment and is eligible to receive significant development, regulatory and commercialization milestone payments up to a potential total of $817M.
CNN talks to an infectious disease physician about the possibilities of becoming infected with Ebola on a flight.
Both Dallas nurses infected while treating an Ebola patient have been flown to better equipped facilities.
House Republicans demanded a travel ban from Ebola-ravaged West Africa Thursday, calling it the only sure way to protect Americans from the virus's deadly reach. Administration officials resisted, as anxiety over the disease raced through the country and rattled the White House and Capitol Hill.
Facing renewed criticism about the U.S. response to Ebola, President Barack Obama is conceding that it may make sense to have a single person lead the administration's effort. But he says imposing a travel ban from disease-ravaged West Africa, as Republicans have demanded, would be counterproductive.
Nuvo Research Inc. has completed the sale of its PENNSAID 2% U.S. sales and marketing rights to Horizon Pharma for a cash payment of US$45 million (CDN$50 million) which was payable on closing.
Shares of Sarepta Therapeutics jumped 11 percent before the opening bell Friday after the drug developer said its potential Ebola treatment generated no safety concerns in early-stage human testing.
Federal health advisers say a bold-letter warning about suicide risks with Pfizer's Chantix should remain on the anti-smoking drug until it can reevaluated based on new, rigorous study information. Eleven advisers to the Food and Drug Administration voted to retain the so-called black box warning.
The development of a vaccine to prevent Ebola virus disease will be accelerated with support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR).
Eli Lilly and Company has announced plans to conclude production and pursue a sale of one of its three manufacturing plants in Puerto Rico. The manufacturing site, located in Guayama, Puerto Rico, will remain in operation until the end of 2015.
It’s not big news that most of America is tired. Wherever your look people are yawning – in the car, in the office, in front of the TV – Americans seem to be tired all the time.